These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 19241289)

  • 21. [Uveitis: diagnostic approach].
    Martínez-Berriotxoa A; Fonollosa A; Artaraz J
    Rev Clin Esp; 2012 Oct; 212(9):442-52. PubMed ID: 22296724
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fluorescein angiographic findings in cases with intermediate uveitis in the inactive phase.
    Gürlü VP; Alimgil ML; Esgin H
    Can J Ophthalmol; 2007 Feb; 42(1):107-9. PubMed ID: 17361250
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intermediate uveitis: long-term course and visual outcome.
    Vidovic-Valentincic N; Kraut A; Hawlina M; Stunf S; Rothova A
    Br J Ophthalmol; 2009 Apr; 93(4):477-80. PubMed ID: 19066184
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fluorescein angiography in intermediate uveitis.
    Schmidt F
    Dev Ophthalmol; 1992; 23():139-44. PubMed ID: 1730346
    [No Abstract]   [Full Text] [Related]  

  • 25. Role of ultra-widefield fluorescein angiography in the management of uveitis.
    Hong BK; Nazari Khanamiri H; Rao NA
    Can J Ophthalmol; 2013 Dec; 48(6):489-93. PubMed ID: 24314409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intermediate uveitis: a hospital based study.
    Malla OK; Karki DB; Byanju RN; Shrestha S
    Kathmandu Univ Med J (KUMJ); 2004; 2(4):354-9. PubMed ID: 16388249
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Application fluorescein angiography: a new method for assessment of anterior eye segment hemomicrocirculation].
    Petraevskiĭ AV; Gndoian IA
    Vestn Oftalmol; 2014; 130(2):12-9. PubMed ID: 24864494
    [TBL] [Abstract][Full Text] [Related]  

  • 28. VASOPROLIFERATIVE TUMORS IN INTERMEDIATE UVEITIS.
    Pichi F; Neri P; Agarwal A; Invernizzi A; Choudhry N; Amer R; Lembo A; Nucci P; Thompson I; Sen HN; Shields CL
    Retina; 2020 Sep; 40(9):1765-1773. PubMed ID: 31584561
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Retinal changes in intermediate uveitis].
    Rícarová R; Tĕsínský P; Hadrávek G
    Cesk Oftalmol; 1990 Mar; 46(2):134-8. PubMed ID: 2334984
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Laser photocoagulation of retinal neovascularization in intermediate uveitis.
    Franklin RM
    Dev Ophthalmol; 1992; 23():251-60. PubMed ID: 1730365
    [No Abstract]   [Full Text] [Related]  

  • 31. Young age as a risk factor for complicated course and visual outcome in intermediate uveitis in children.
    Kalinina Ayuso V; ten Cate HA; van den Does P; Rothova A; de Boer JH
    Br J Ophthalmol; 2011 May; 95(5):646-51. PubMed ID: 20921016
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Wide-field retinal imaging in the management of noninfectious posterior uveitis.
    Campbell JP; Leder HA; Sepah YJ; Gan T; Dunn JP; Hatef E; Cho B; Ibrahim M; Bittencourt M; Channa R; Do DV; Nguyen QD
    Am J Ophthalmol; 2012 Nov; 154(5):908-911.e2. PubMed ID: 22935598
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Estimation of immunological markers in children with intermediate uveitis symptoms].
    Turno-Krecicka A; Polańska B; Turska M; Barć A
    Klin Oczna; 2006; 108(7-9):306-11. PubMed ID: 17290830
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ultra wide-field imaging of choroidal metastasis secondary to primary breast cancer.
    Coffee RE; Jain A; McCannel TA
    Semin Ophthalmol; 2009; 24(1):34-6. PubMed ID: 19241290
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravitreal and orbital floor triamcinolone acetonide injections in noninfectious uveitis: a comparative study.
    Roesel M; Gutfleisch M; Heinz C; Heimes B; Zurek-Imhoff B; Heiligenhaus A
    Ophthalmic Res; 2009; 42(2):81-6. PubMed ID: 19478546
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pattern of Intermediate Uveitis in an Egyptian Cohort.
    Abd El Latif E; Abdelhalim AS; Montasser AS; Said MH; Shikhoun Ahmed M; Abdel Kader Fouly Galal M; Ibrahim W; Samy Abd Elaziz M; Fathi Abuelkheir A; Elbarbary H; Elsayed AMA; Lotfy A; Elmorsy OA; Gab-Alla AA; Hatata RM; Abousamra AAH; Farouk MM; Elbakary MA; Awara AM; Amer I; Elzawahry WMAE; Kandil HW; Barrada OA; Bakr Elessawy K; Zayed MA; El Hennawi H; Tawfik MA
    Ocul Immunol Inflamm; 2020 Apr; 28(3):524-531. PubMed ID: 31642742
    [No Abstract]   [Full Text] [Related]  

  • 37. Ranibizumab for refractory uveitis-related macular edema.
    Acharya NR; Hong KC; Lee SM
    Am J Ophthalmol; 2009 Aug; 148(2):303-309.e2. PubMed ID: 19427988
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Retinal periphlebitis in a patient with pineal germinoma.
    Chang CW; Hay D; Chang TS; Nguyen R; Lyons CJ
    Arch Ophthalmol; 1999 Oct; 117(10):1434-6. PubMed ID: 10532463
    [No Abstract]   [Full Text] [Related]  

  • 39. Dexamethasone posterior-segment drug delivery system in the treatment of macular edema resulting from uveitis or Irvine-Gass syndrome.
    Williams GA; Haller JA; Kuppermann BD; Blumenkranz MS; Weinberg DV; Chou C; Whitcup SM;
    Am J Ophthalmol; 2009 Jun; 147(6):1048-54, 1054.e1-2. PubMed ID: 19268890
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patients with Multiple Sclerosis and concomitant uveitis/periphlebitis retinae are not distinct from those without intraocular inflammation.
    Schmidt S; Wessels L; Augustin A; Klockgether T
    J Neurol Sci; 2001 Jun; 187(1-2):49-53. PubMed ID: 11440744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.